292 related articles for article (PubMed ID: 22922344)
1. Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8).
Tang W; Zuo JP
Acta Pharmacol Sin; 2012 Sep; 33(9):1112-8. PubMed ID: 22922344
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii.
Ma J; Dey M; Yang H; Poulev A; Pouleva R; Dorn R; Lipsky PE; Kennelly EJ; Raskin I
Phytochemistry; 2007 Apr; 68(8):1172-8. PubMed ID: 17399748
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f.
Qiu D; Kao PN
Drugs R D; 2003; 4(1):1-18. PubMed ID: 12568630
[TBL] [Abstract][Full Text] [Related]
4. [Advances in the study of immunopharmacological effects and mechanisms of extracts of Tripterygium wilfordii Hook. f. in neuroimmunologic disorders].
Pan XD; Chen XC
Yao Xue Xue Bao; 2008 Dec; 43(12):1179-85. PubMed ID: 19244746
[TBL] [Abstract][Full Text] [Related]
5. Triptolide: progress on research in pharmacodynamics and toxicology.
Li XJ; Jiang ZZ; Zhang LY
J Ethnopharmacol; 2014 Aug; 155(1):67-79. PubMed ID: 24933225
[TBL] [Abstract][Full Text] [Related]
6. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F.
Chen BJ
Leuk Lymphoma; 2001 Jul; 42(3):253-65. PubMed ID: 11699390
[TBL] [Abstract][Full Text] [Related]
7. Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects.
Song CY; Xu YG; Lu YQ
J Zhejiang Univ Sci B; 2020 Apr.; 21(4):280-290. PubMed ID: 32253838
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice.
Luo D; Zuo Z; Zhao H; Tan Y; Xiao C
Front Med; 2019 Oct; 13(5):556-563. PubMed ID: 30604167
[TBL] [Abstract][Full Text] [Related]
9. Triptolide: reflections on two decades of research and prospects for the future.
Tong L; Zhao Q; Datan E; Lin GQ; Minn I; Pomper MG; Yu B; Romo D; He QL; Liu JO
Nat Prod Rep; 2021 Apr; 38(4):843-860. PubMed ID: 33146205
[TBL] [Abstract][Full Text] [Related]
10. [Progress of effect and mechanisms of Tripterygium wilfordii on immune system].
Nong C; Wang XZ; Jiang ZZ; Zhang LY
Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3374-3383. PubMed ID: 31602898
[TBL] [Abstract][Full Text] [Related]
11. The Pharmacological Effects and Mechanism of Tripterygium wilfordii Hook F in Central Nervous System Autoimmunity.
Wang Q; Meng J; Dong A; Yu JZ; Zhang GX; Ma CG
J Altern Complement Med; 2016 Jul; 22(7):496-502. PubMed ID: 27224044
[TBL] [Abstract][Full Text] [Related]
12. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae).
Brinker AM; Ma J; Lipsky PE; Raskin I
Phytochemistry; 2007 Mar; 68(6):732-66. PubMed ID: 17250858
[TBL] [Abstract][Full Text] [Related]
13. Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases.
Han R; Rostami-Yazdi M; Gerdes S; Mrowietz U
Br J Clin Pharmacol; 2012 Sep; 74(3):424-36. PubMed ID: 22348323
[TBL] [Abstract][Full Text] [Related]
14. [Progress in research on mechanisms of anti-rheumatoid arthritis of triptolide].
Liu CF; Lin N
Zhongguo Zhong Yao Za Zhi; 2006 Oct; 31(19):1575-9. PubMed ID: 17165577
[TBL] [Abstract][Full Text] [Related]
15. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
[TBL] [Abstract][Full Text] [Related]
16. [16-Hydroxytriptolide, a new active diterpene isolated from Tripterygium wilford II].
Ma PC; Lu XY; Yang JJ; Zheng QT
Yao Xue Xue Bao; 1991; 26(10):759-63. PubMed ID: 1823717
[TBL] [Abstract][Full Text] [Related]
17. Triptolide and its expanding multiple pharmacological functions.
Liu Q
Int Immunopharmacol; 2011 Mar; 11(3):377-83. PubMed ID: 21255694
[TBL] [Abstract][Full Text] [Related]
18. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F.
Tao X; Cai JJ; Lipsky PE
J Pharmacol Exp Ther; 1995 Mar; 272(3):1305-12. PubMed ID: 7891348
[TBL] [Abstract][Full Text] [Related]
19. Immunochemical characterization of the functional constituents of Tripterygium wilfordii contributing to its anti-inflammatory property.
Wong KF; Chan JK; Chan KL; Tam P; Yang D; Fan ST; Luk JM
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):55-9. PubMed ID: 18047628
[TBL] [Abstract][Full Text] [Related]
20. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production.
Tao X; Schulze-Koops H; Ma L; Cai J; Mao Y; Lipsky PE
Arthritis Rheum; 1998 Jan; 41(1):130-8. PubMed ID: 9433878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
